ARCHIVES

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

October 20, 1995

In Brief: ONS Forms Six New Special Interest Groups; Four Named To Michigan Breast Cancer Center

April 13, 1990

Moyniham Bill Will Direct HHS to Exempt Centers Recognized By NCI From Prospective Payment System

August 15, 1986

NCI Management Director Leaving For Case Institute.

October 12, 2001

NCI Advisory Group, Other Cancer Meetings

February 22, 1985

Young Elected ACS President, Von eschenback Pres.-Elect.

November 9, 2001